Burney Company’s Globus Medical GMED Stock Holding History

Burney Company’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,345	Closed	-$1.06M	–	627
2026 Q1	$1.06M	Buy	+12,345	New	+$1.11M	0.03%	324

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Burney Company's GMED Position: Q2 2026 in Review

Burney Company sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 12,345 shares — an estimated $1.06M sold.

Burney Company first reported a position in GMED in Q1 2026 and held it in 1 quarter. The position peaked at $1.06M in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Burney Company reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Burney Company sold 12,345 Globus Medical shares in Q2 2026, an estimated $1.06M.
Burney Company first reported a position in Globus Medical in Q1 2026 and held it in 1 quarter.
Burney Company's Globus Medical position peaked at $1.06M in Q1 2026.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.